Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,366 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06799780Recruiting
Surgery for heart hole after heart attack: timing study
This study looks at people who had a hole in their heart after a heart attack and had surgery to fix it. The goal is to understand how the timing of surgery affects recovery.
Bologna, BolognaAges 18 years+ - NCT06799611RecruitingPhase 2
CM336 for immune thrombocytopenia (ITP)
This trial tests a new drug called CM336 for people with immune thrombocytopenia (ITP) that hasn't responded well to other treatments. It aims to see if CM336 can safely help raise platelet counts and reduce bleeding risk.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06798987Enrolling by invitation
Weather and pollution impact on emergency calls in Zhejiang
This study looks at data from the Zhejiang Emergency Command Center to see how weather and pollution affect the number of emergency calls. It aims to find out which people and health conditions are most sensitive to these factors.
HangzhouAges Any age - NCT04819217Recruiting
Probiotics and a toxin binder to slow chronic kidney disease
This trial studies an oral product (a “uremic toxin” absorber) plus probiotics to help slow the progression of chronic kidney disease. It may help by lowering harmful gut-related substances that can build up when kidney function is reduced.
TaipeiAges 20 years+ - NCT06440525RecruitingPhase 2
Testing RSLV-132 for Sjögren's disease in women
This study tests an investigational drug called RSLV-132 in women with Sjögren's disease to see if it can reduce symptoms like fatigue and dryness. You may join if you've been diagnosed in the last 30 years and have persistent symptoms.
Chula Vista, CaliforniaAges 18–75 - NCT04113447Recruiting
Mitochondrial donation study for parents of confirmed mtDNA mutation
This study follows families using mitochondrial donation to reduce the risk from a confirmed mitochondrial DNA (mtDNA) mutation. It aims to learn outcomes over about 18 months of the child’s life and whether the treatment works well and safely for families like yours.
Newcastle upon Tyne, Tyne & WearAges Any age - NCT06771193Recruiting
Study of cervical cancer treatment patterns in Italy
This study looks at the types of treatments and disease characteristics in people with cervical cancer that is locally advanced (cannot be removed by surgery) or has come back or spread. It may help doctors understand how different treatments are used in Italy.
Bologna, BolognaAges 18 years+ - NCT06790836Recruiting
CT scan vs. invasive test for heart artery blood flow
This study looks at how well a special CT scan (FFR CT) matches the results of a more invasive wire test (invasive FFR) for measuring blood flow in heart arteries. It may help doctors use CT scans more confidently instead of always needing the invasive procedure.
Birmingham, West MidlandsAges 18 years+ - NCT06791902Recruiting
Adaptive brain stimulation for walking problems in Parkinson's
This study tests a new type of deep brain stimulation (DBS) that automatically adjusts to your walking or balance issues. It uses your brain's own signals to improve movement.
Lausanne, Canton of VaudAges 18 years+ - NCT06785363Enrolling by invitation
Pelvic ligament release for postpartum back pain
This study tests a technique to release a tight pelvic ligament that can cause lower back pain after pregnancy. It may help women who recently gave birth and have mechanical back or pelvic pain.
CairoAges 25–30 - NCT06780046Recruiting
COPD study for Brazilian patients
This study looks at the health of Brazilian adults with COPD. It aims to understand how the condition affects people and may help improve future treatments.
Aparecida de GoiâniaAges 18 years+ - NCT06780670RecruitingPhase 2/Phase 3
Comparing a new treatment to standard care for advanced prostate cancer
This study tests a new drug (AAA817) against the usual treatments for men with advanced prostate cancer that has stopped responding to a type of targeted radiation therapy (Lu-PSMA). The goal is to see if the new drug can slow the cancer's growth better than standard options.
Scottsdale, ArizonaAges 18–100 - NCT06775912RecruitingEarly Phase 1
CAR-T cell therapy for autoimmune diseases
This trial tests a new CAR-T cell therapy that targets two proteins (CD19 and BCMA) on immune cells. It's designed for people with certain autoimmune diseases like lupus, scleroderma, vasculitis, myositis, or Sjögren's syndrome that are not controlled by standard treatments.
Lianyungang, JiangusAges 18–70 - NCT06772623RecruitingPhase 1/Phase 2
Study of telisotuzumab adizutecan plus immunotherapy for advanced lung cancer
This trial tests a new combination treatment for people with advanced non-squamous non-small cell lung cancer who haven't received prior therapy for advanced disease and don't have specific gene changes. The treatment includes an antibody-drug conjugate (telisotuzumab adizutecan) plus an immunotherapy drug (PD-1 checkpoint inhibitor) to see if it helps shrink tumors and improve outcomes.
Phoenix, ArizonaAges 18 years+ - NCT06780176Recruiting
Breast cancer risk study for people in Florida
This study looks at breast cancer risk factors and outcomes by inviting people who are getting breast biopsies or are new breast patients at certain Florida hospitals to complete a survey. It aims to better understand what affects breast cancer risk and treatment results.
Los Angeles, CaliforniaAges 18 years+ - NCT06778070Recruiting
Pelvic pain study testing yoga therapy for relief
This trial tests whether yoga therapy can help reduce chronic pelvic pain in women and non-binary individuals over 6 months. You'll join online yoga classes and see if they improve your pain and daily life.
San Francisco, CaliforniaAges 18 years+ - NCT06776510RecruitingPhase 1/Phase 2
NAD for immune thrombocytopenia study
This trial tests if a substance called NAD can help adults with immune thrombocytopenia (ITP) whose platelet levels stay low even after standard treatments. ITP is a condition where the immune system attacks platelets, causing easy bruising and bleeding. The study aims to see if NAD can safely raise platelet counts.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06774690Recruiting
Arterial treatments for primary liver cancer
This study is watching how treatments that deliver medicine or tiny beads directly into the liver's blood supply work for people with liver cancer. If you have liver cancer and are getting or have gotten one of these treatments, this study wants to learn from your experience.
BolognaAges 18 years+ - NCT06774586Recruiting
Study of blood vessel health in children
This study examines the health of blood vessels in children ages 6 to 17, using a non-invasive device called Vicorder to measure vessel stiffness. It aims to understand how blood vessel walls work in youth.
BolognaAges 6–17 - NCT06249438RecruitingPhase 1
CAR-T cell therapy for hard-to-treat autoimmune diseases
This trial tests a new CAR-T cell therapy (C-CAR168) for people with several autoimmune diseases that have not responded to standard treatments. It aims to see if this therapy can control the disease when other medicines have failed.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06766357RecruitingPhase 3
Cyclosporin gel for moderate to severe dry eye
This study tests a gel form of cyclosporine for people with moderate to severe dry eye that hasn't improved with other treatments. The gel is applied to the eye to help reduce inflammation and increase tear production.
Xiamen, FujianAges 18 years+ - NCT06764706Recruiting
Risankizumab for moderate-to-severe ulcerative colitis
This study observes how well risankizumab works for people with moderate to severe ulcerative colitis who are already starting it as part of their regular care. It helps doctors learn more about the drug's real-world effects.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT06765850Recruiting
Melanoma blood marker study
This study looks at small molecules in your blood (called the metabolome) using special tests. Researchers want to see if these molecules change depending on how your melanoma progresses, which may help improve future care.
Dresden, SaxonyAges 18 years+ - NCT06768398Recruiting
AI study for heart and blood vessel health
This study uses artificial intelligence (AI) to analyze medical images of blood vessels. It aims to help patients with heart or blood vessel conditions, including smokers and those with high blood pressure, by improving how doctors spot problems early.
ShatinAges 19 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,366 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.